Sofia, Bulgaria, August 11, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 8, 2025 the Company sold 7 300 (seven thousand three hundred) repurchased own shares representing 0.001% of the share capital of the Company, at a total value of BGN 17 926.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.

Sofia, Bulgaria, August 11, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 7, 2025 the Company sold 8 400 (eight thousand four hundred) repurchased own shares representing 0.002% of the share capital of the Company, at a total value of BGN 20 496.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.44.

Sofia, Bulgaria, August 7, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 6, 2025 the Company sold 6 000 (six thousand) repurchased own shares representing 0.001% of the share capital of the Company, at a total value of BGN 14 580.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.43.